June Bray - 11 Jun 2021 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
Director
Signature
/s/ Richard I. Steinhart, Attorney-in-Fact for June Bray
Issuer symbol
BTAI
Transactions as of
11 Jun 2021
Net transactions value
$0
Form type
4
Filing time
15 Jun 2021, 17:32:52 UTC
Next filing
23 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 11 Jun 2021 Common Stock 25,000 $37.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full and become exercisable in three substantially equal annual installments following the date of grant, such that the option shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continued service through such vesting date.